Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03488927 · ClinicalTrials.gov registry record · NA

Development and Pilot Trial of an Intervention to Reduce Disclosure Recipients Negative Social Reactions and Victims Psychological Distress and Problem Drinking

A NA study of Depression and Post Traumatic Stress Disorder, sponsored by University of New Hampshire.

Completed
Registry status
NA
Development phase
1,268
Enrollment target
1
Study location

NCT03488927: Completed NA study of Depression and Post Traumatic Stress Disorder, sponsored by University of New Hampshire.

NCT03488927 is a NA study of Depression and Post Traumatic Stress Disorder that has completed, run by University of New Hampshire. The registered enrollment target is 1,268 participants, above the 784-participant average among 679 other Depression trials with a reported enrollment target (62% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03488927, a NA study of Depression and Post Traumatic Stress Disorder, has completed, sponsored by University of New Hampshire.

COMPLETED
Registry status
NA
Development phase
1,268 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized controlled trial is to evaluate an intervention, Supporting Survivors and Self: An Intervention for Social Supports of Survivors of Partner Abuse and Sexual Aggression (SSS). SSS trains potential recipients of IPV or SA disclosure on the best methods of responding to a victim's disclosure. Consenting college students will be randomized into the SSS intervention or a wait-list control condition. Evaluation data will be multi-informant (i.e., data from both informal supports and victims) and multi-method (i.e., qualitative and quantitative). The investigators hypothesize that individuals receiving the SSS intervention, compared to individuals in the wait-list control condition, will provide less negative and more positive social reactions to victims' disclosure.

Primary Outcome

As measured by the Social Reactions Questionnaire (at six month follow-up). This scale is measured from 1 to 6, with higher mean scores representing a less desirable outcome.

Interventions

  • BEHAVIORAL Supporting Survivors and Self: An Intervention for Social Supports of Survivors of Partner Abuse and Sexual Aggression (SSS)

Study Locations (1)

New Hampshire

  • University of New Hampshire - Durham

Trial Details

FieldValue
Enrollment Target 1,268 participants
Start Date 2018-09-10
Est. Completion 2019-06-10
Phase NA
University of New Hampshire

10 total trials

What the finished NCT03488927 record still lists

NCT03488927 is an interventional study that assigns participants to a tested intervention. Its 1,268 participants enrollment target places it among the larger protocols in the corpus, above the 784-participant average among 679 other Depression trials with a reported enrollment target (62% higher).

The record links to 10 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Supporting Survivors and Self: An Intervention for Social Supports of Survivors of Partner Abuse and Sexual Aggression (SSS) is the first listed.

NCT03488927 reports a single indexed study location in New Hampshire.

Frequently Asked Questions

What is clinical trial NCT03488927 about?

NCT03488927 is a clinical study titled "Development and Pilot Trial of an Intervention to Reduce Disclosure Recipients Negative Social Reactions and Victims Psychological Distress and Problem Drinking". The purpose of this randomized controlled trial is to evaluate an intervention, Supporting Survivors and Self: An Intervention for Social Supports of Survivors of Partner Abuse and Sexual Aggression (SSS). SSS trains potential recipients of IPV or SA disclosure on the best methods of responding to a...

What is the current status of trial NCT03488927?

This trial is currently completed. It is a NA study. The enrollment target is 1,268 participants. The study started on 2018-09-10. Estimated completion is 2019-06-10.

What conditions does trial NCT03488927 study?

This clinical trial studies the following conditions: Depression, Post Traumatic Stress Disorder, Alcohol Drinking, Alcohol Abuse, Alcohol; Harmful Use.

What interventions are being tested in trial NCT03488927?

The interventions under investigation include: Supporting Survivors and Self: An Intervention for Social Supports of Survivors of Partner Abuse and Sexual Aggression (SSS) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03488927?

This trial is sponsored by University of New Hampshire, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03488927 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03488927's enrollment target sits among peer trials

1,268 33rd of 679 higher than 647 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06790641 · 1,270 participants · NA

    Pathways to Perinatal Mental Health Equity

  • NCT06876246 · 1,270 participants · NA

    SBIR/ STTR Family Check-up Online

  • NCT06119581 · 1,264 participants · Phase 3

    A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • NCT03678025 · 1,273 participants · Phase 3

    Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT03488927, the US trial registry maintained by the National Library of Medicine. NCT03488927 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.